|
Volumn 24, Issue 6, 2005, Pages 731-734
|
Multivariate prognostic analysis for patients with unresectable esophageal carcinoma after concurrent chemoradiotherapy
a a a a a,a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
FLUOROURACIL;
ADULT;
AGED;
ARTICLE;
CANCER STAGING;
ESOPHAGUS TUMOR;
FEMALE;
FOLLOW UP;
HUMAN;
LYMPH NODE METASTASIS;
MALE;
MEGAVOLTAGE RADIOTHERAPY;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
MULTIVARIATE ANALYSIS;
PATHOLOGY;
PROGNOSIS;
PROPORTIONAL HAZARDS MODEL;
SQUAMOUS CELL CARCINOMA;
TUMOR RECURRENCE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
COMBINED MODALITY THERAPY;
ESOPHAGEAL NEOPLASMS;
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
HUMANS;
LYMPHATIC METASTASIS;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
RADIOTHERAPY, HIGH-ENERGY;
|
EID: 39049176716
PISSN: 1000467X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|